Source: Eur Respir J 2008; 31: 563-570
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Brekke P. H., Omland T., Holmedal S. H., Smith P., Soyseth V.. Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 2008; 31: 563-570

Member's Comments

No comment yet.

Related content which might interest you: Troponin T elevation and one year mortality after acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Predictors of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Cardiac troponin T levels increase overnight in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019